Otolaryngology Doctors in Walla Walla, WA Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Gary Mcclendon Crabtree, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1125 S 2nd Ave Ste B, Walla Walla, WA 99362 Phone: 509-529-6673

Glyn E Marsh, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 301 W Poplar St, Suite 210, Walla Walla, WA 99362 Phone: 509-522-5825    Fax: 509-529-3512

Gregory Alan Haveman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 320 W Willow St, Walla Walla, WA 99362 Phone: 509-525-3720    Fax: 509-522-1592

Dr. Philip R Morgan, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 320 Willow, Walla Walla, WA 99362 Phone: 509-525-3720    Fax: 509-529-9939

News Archive

UPC develops new system for electroporation of cell cultures

Researchers from the Polytechnic University of Catalonia have developed a technique that improves and cuts the cost of a technique called electroporation, which involves opening pores in cell membranes using an electric field to introduce substances like drugs and DNA. Current methods are aggressive and expensive whereas the new system manages to apply low voltage electroporation with a small printed circuit board, which costs less than a Euro per unit and does not damage cells.

Large clinical trial to assess safety, efficacy of two experimental Ebola vaccines opens in Liberia

A large clinical trial to assess the safety and efficacy of two experimental vaccines to prevent Ebola virus infection is now open to volunteers in Liberia. The trial is being led by a recently formed Liberia-U.S. clinical research partnership and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Experts discuss global threat of Alzheimer's disease at House subcommittee hearing

"Alzheimer's experts urged U.S. lawmakers on Thursday to increase funding for research of the debilitating disease and to push international policymakers to pay more attention to its global impact," Reuters reports (Steenhuysen, 6/23).

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

Read more Medical News

› Verified 4 days ago